Chester County News and Community Website
BERWYN, PA — Panavance Therapeutics Inc. has shared promising interim findings from its ongoing Phase 1 clinical trial investigating misetionamide (GP-2250), a novel second-line therapy for advanced pancreatic cancer. These …
Panavance Therapeutics Reports Promising Phase 1 Results for Pancreatic Cancer Therapy Read More
PLYMOUTH MEETING, PA — Research published in the April 2025 issue of JNCCN–Journal of the National Comprehensive Cancer Network has revealed stark disparities in the quality of care and outcomes …
Study Reveals Disparities in Care for Metastatic Pancreatic Cancer Patients Read More
PHILADELPHIA, PA — Golden Digital has partnered with Modern Prairie, founded by Melissa Gilbert, to unveil a special initiative supporting Pancreatic Cancer Awareness Month. The collaboration has resulted in the …
Golden Digital and Modern Prairie Launch Collection for Pancreatic Cancer Awareness Read More BERWYN, PA — Panavance Therapeutics Inc. announced interim results from its Phase 1 clinical trial at the 2024 Visceral Medicine Congress in Leipzig, Germany. The study evaluates the safety and efficacy …
Panavance Unveils Game-Changing Data: A New Hope for Pancreatic Cancer Patients? Read More
PLYMOUTH MEETING, PA — A groundbreaking study published in the April 2024 issue of JNCCN—Journal of the National Comprehensive Cancer Network demonstrates potential strides toward better early detection and prevention …
Global Consortium Shows Promise in Early Detection of Pancreatic Cancer Read More